Nachrichten zur Pfizer Inc. Aktie

Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst

…

Pfizer Stock Has 30% Upside, According to 1 Wall Street Analyst

Income investors can enjoy the nearly 6% dividend yield even if growth doesnt return.…

Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb

The dynamics of the follicular lymphoma market are anticipated to change in the coming years owing to the improvement in…

Pfizer: Kurzfristige Schätzungen könnten steigen, wenn... - Aktienanalyse

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Guggenheim Securities: Guggenheim Securities nimmt in einer aktuellen Aktienanalyse die Coverage der Aktie von Pfizer…

Pfizer: Finally, A Dividend Stock Worth Buying

…

Pfizer files automatic mixed shelf

…

Pfizer Stock Has 29% Upside, Says a New Bull

…

Here are Fridays biggest analyst calls: Rivian, DraftKings, Nio, Fox, Carvana, Pfizer and more

These are some of the biggest calls out of Wall Street on Friday.…

Pfizer stock is the new Buy at Guggenheim By Investing.com

Pfizer stock is the new Buy at Guggenheim…

Guggenheim sets Pfizer stock with buy rating, $36 target By Investing.com

Guggenheim sets Pfizer stock with buy rating, $36 target…

Pharma Stock Roundup: Pfizers Velsipity Receives EU Nod, ABBV Gets New CEO & More

European Commission approves Pfizers (PFE) Velsipity ulcerative colitis (UC) pill. AbbVie (ABBV) appoints Robert A. Michael as the new CEO.…

Pfizers Post-Pandemic Pivot

…

Moderna CEO: Excited About Future Following 4Q Revenue

Moderna Inc. reported fourth-quarter revenue that beat analysts’ expectations by gaining Covid vaccine market share on its rival, Pfizer Inc, posting quarterly…

Pfizer: Turnaround Is Gaining Momentum

…

Pfizers (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

The approval for Pfizers (PFE) Velsipity (etrasimod) is based on data from two pivotal phase III studies, ELEVATE UC 52…

Pfizers Expansion Sparks Boom for these Healthcare REITs

…

Pharmakonzern Daiichi Sankyo investiert eine Mrd Euro in Bayern

München (Reuters) - Der japanische Pharmakonzern Daiichi Sankyo will sein Werk im bayerischen Pfaffenhofen an der Ilm für eine Milliarde…

How To Earn $1,000 Per Month From Pfizer Stock

…

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

PALM BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous reports indicate…

Pfizer Stock: Its Time To Buy The Dip

…

Pfizer touts cancer efforts in first Super Bowl commercial

…

Pfizer Is A Great Investment Over The Next Decade; Buy

…

Pharma Stocks: 5 Biggest Companies in 2024

The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…

Pfizer might get Alzheimers lift from Viagra, study suggests

Pfizer had some rare good news in a tough twelve months for the US pharma as a new study suggested…

How To Earn $500 Per Month From Pfizer Stock

…

Pfizers Problems Go Far Beyond Just Declining COVID Revenue

…

Pfizer: Auf der Suche nach Wachstum - Aktienanalyse

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

Hemostasis Products Market revenue to hit USD 1.73 Billion by 2033, says Research Nester

Prominent hemostasis products market players include Terumo Corporation, Baxter International, Inc., Sysmex Asia Pacific Pte Ltd, Abbott Healthcare Private Limited,…

Better Dividend Stock: Pfizer vs. AbbVie @themotleyfool #stocks $ABBV $PFE

Both offer above-average yields but which can deliver the most dividend income over the long run?…

Better Dividend Stock: Pfizer vs. AbbVie

…

Better Dividend Stock: Pfizer vs. AbbVie

Both offer above-average yields but which can deliver the most dividend income over the long run?…

Share Market Highlights 5 February 2024: Sensex falls 354 pts; Nifty settles above 21,750 pts; Tata Motors gains over 5%, UPL slumps over 10%

Sensex, Nifty updates on 5 February 2024 -- BSE Sensex fell 0.49% to close at 71,731.42 points and NSE Nifty…

dpa-AFX ProFeed